Clinical Updates in Cardiac Electrophysiology: 2nd Edition

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 25 July 2025 | Viewed by 1033

Special Issue Editor


E-Mail Website
Guest Editor
Division of Cardiovascular Medicine, University of Virginia Health System, 1215 Lee Street, Charlottesville, VA, USA
Interests: arrhythmias; heart rhythm disorders; atrial fibrillation (Afib); catheter ablation; heart devices for Afib; pacemakers; conduction system pacing; left bundle branch area pacing; artificial intelligence; digital health; cardiac magnetic resonance; supraventricular tachycardia; sudden cardiac arrest; ventricular tachycardia; heart genetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is my pleasure to invite you to contribute to this Special Issue, entitled “Clinical Updates in Cardiac Electrophysiology: 2nd Edition”. This is a new volume, with seven papers being in the first one. For more details, please visit https://www.mdpi.com/journal/jcm/special_issues/0C8X5A26KV.

The Journal of Clinical Medicine (a renowned journal with an impact score of 3.0 and a CiteScore of 5.7) is pleased to announce a new Special Issue titled “Clinical Advancements in Cardiac Electrophysiology: 2nd Edition”. In recent years, there have been significant developments in the fields of catheter ablation, conduction system pacing, left atrial appendage occlusion, leadless pacing, remote monitoring, artificial intelligence, and digital health. These improvements are expected to have a major impact on patients with heart rhythm disorders and heart failure in the coming years. Thus, the dissemination of these findings to a broad audience is crucial.

Therefore, this Special Issue invites original research and systematic reviews to provide an update on the clinical progress related to treatment approaches, predictors of outcomes, advanced cardiac imaging (including cardiac magnetic resonance), remote monitoring, digital health, and artificial intelligence for heart rhythm disorders.

Prof. Dr. Kenneth C. Bilchick
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • arrhythmias
  • atrial fibrillation
  • cardiac electrophysiology
  • heart rhythm disorders
  • ablation
  • ventricular tachycardia
  • remote monitoring
  • digital health
  • artificial intelligence
  • cardiac magnetic resonance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 710 KiB  
Review
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence
by Alfredo Mauriello, Adriana Correra, Anna Chiara Maratea, Alfredo Caturano, Biagio Liccardo, Marco Alfonso Perrone, Antonio Giordano, Gerardo Nigro, Antonello D’Andrea and Vincenzo Russo
J. Clin. Med. 2025, 14(5), 1652; https://doi.org/10.3390/jcm14051652 - 28 Feb 2025
Viewed by 855
Abstract
Dyslipidemia is a metabolic disorder characterized by quantitative and/or qualitative abnormalities in serum lipid levels. Elevated serum cholesterol levels can modify the turnover and recruitment of ionic channels in myocytes and cellular homeostasis, including those of inflammatory cells. Experimental and clinical data indicate [...] Read more.
Dyslipidemia is a metabolic disorder characterized by quantitative and/or qualitative abnormalities in serum lipid levels. Elevated serum cholesterol levels can modify the turnover and recruitment of ionic channels in myocytes and cellular homeostasis, including those of inflammatory cells. Experimental and clinical data indicate that inflammation is implicated in the pathophysiology of atrial remodeling, which is the substrate of atrial fibrillation (AF). Data about the association between increased lipid serum levels and AF are few and contrasting. Lipoprotein (a), adiposity, and inflammation seem to be the main drivers of AF; in contrast, low-density lipoproteins, high-density lipoproteins and triglycerides are not directly involved in AF onset. The present review aimed to describe the pathophysiological link between dyslipidemia and AF, the efficacy of lipid-lowering therapies in atherosclerotic cardiovascular disease (ASCVD) patients with and without AF, and the impact of lipid-lowering therapies on AF incidence. Full article
(This article belongs to the Special Issue Clinical Updates in Cardiac Electrophysiology: 2nd Edition)
Show Figures

Figure 1

Back to TopTop